Showing results (141-150 of 181) with videos related to
Sort By:
Pageof 19
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology]Anton Vonk-Noordegraaf, François Haddad, Kelly M Chin, et al.Journal of the American College of Cardiology|December 20, 2008
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trialXavier Jaïs, Andrea M D'Armini, Pavel Jansa, et al.European Journal of Heart Failure|July 5, 2024
Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbiditiesVallerie V McLaughlin, Olivier Sitbon, Kelly M Chin, et al.JHLT Open|March 27, 2025
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertensionRichard Channick, Sarah Medrek, Marion Delcroix, et al.Seminars in Arthritis and Rheumatism|November 13, 2018
Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertensionAmber Young, Vivek Nagaraja, Mark Basilious, et al.The Lancet. Respiratory Medicine|November 28, 2018
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trialRoela Sadushi-Kolici, Pavel Jansa, Grzegorz Kopec, et al.American Journal of Respiratory and Critical Care Medicine|August 8, 2015
Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial HypertensionRaymond L Benza, Mardi Gomberg-Maitland, Teresa Demarco, et al.Journal of Clinical Medicine|April 3, 2021
Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary HypertensionSzymon Darocha, Aleksander Araszkiewicz, Marcin Kurzyna, et al.The New England Journal of Medicine|March 31, 2020
Apixaban for the Treatment of Venous Thromboembolism Associated with CancerGiancarlo Agnelli, Cecilia Becattini, Guy Meyer, et al.European Heart Journal|March 23, 2017
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertensionNazzareno Galiè, Pavel Jansa, Tomás Pulido, et al.Pageof 19